Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fibrin P2 epitope is a cryptic, pro-inflammatory sequence exposed on the fibrinogen γ chain (amino acids 377–395) after conversion of fibrinogen to insoluble fibrin by thrombin cleavage. This epitope is not accessible in soluble fibrinogen and becomes available only upon formation of cross-linked, insoluble fibrin. Upon exposure, the P2 epitope binds to CD11b/CD18 (complement receptor 3/CR3/Mac-1/αMβ2 integrin) and CD11c/CD18 (CR4/αXβ2 integrins) receptors found on microglia, macrophages, neutrophils, and dendritic cells, triggering innate immune activation and potentially contributing to neurodegenerative diseases.
Blocks innate immune cell activation via CR3/CR4
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin P2 Epitope (Fibrin-P2).